Efficacy of add-on mirtazapine on clinical and neuropsychologic parameters in schizophrenic patients treated with conventional antipsychotics: a double-blind, placebo-controlled trial with an open-label extension phase

Trial Profile

Efficacy of add-on mirtazapine on clinical and neuropsychologic parameters in schizophrenic patients treated with conventional antipsychotics: a double-blind, placebo-controlled trial with an open-label extension phase

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Jan 2013

At a glance

  • Drugs Mirtazapine (Primary)
  • Indications Schizoaffective disorder; Schizophrenia
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 01 Jan 2013 Results reporting effects of treatment on cognition published in Neuropharmacology.
    • 01 Jun 2011 Neurocogntion outcomes were published in the Progress in Neuro-Psychopharmacology and Biological Psychiatry.
    • 06 Apr 2011 Results for extension phase published in the Human Psychopharmacology: Clinical and Experimental.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top